From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Loading…
Align Technology
ALGN · NASDAQ · Health Care Supplies
ALGN · NASDAQ · Health Care Supplies
Health Care Supplies company based in Tempe, Arizona.
In the last 90 days, no insider of Align Technology reported an open-market purchase and 0 open-market sales. The latest 13F reports cover the quarter ending Jun 30, 2026. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$140.65
Last 12 months
+6.4%
Market value
$9.99B
S&P 500 +15.8% over the same dates. Prices adjusted for splits and dividends.
Bets against the stock: 3.9M shares sold short (5.5% of shares outstanding), +1.2% vs the previous count, 4.9 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Revenue
$1.06B
+4.3% vs the same quarter a year earlier
Free cash flow, last 12 months
$634M
This quarter $157M, a year earlier $107M
Net debt
—
Debt —, cash $1.1B, at Jun 30, 2026
Net income, last 12 months
$414M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Jul 29, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$4.03B
+0.9% vs the year before
Net income, fiscal 2025
$410M
As reported in the annual filing
Shares outstanding
71M
As of Jul 31, 2026
In fiscal 2025 the company spent $466M buying back its own shares. Cash actually paid, from its cash-flow statement.
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
4 approvals or clearances and 0 recalls recorded by the FDA for this company and its listed subsidiaries.
From openFDA: Drugs@FDA (new applications and new uses), device 510(k) and PMA decisions, and FDA enforcement reports. Class I recalls are the most serious, Class III the least. Most recalls are started by the company itself. Labeling and manufacturing changes are not listed.
Last 12 months, adjusted daily closes
Adjusted close went from $131.50 on Oct 6, 2025 to $140.65 on Oct 5, 2026 (+7.0%). Disclosed activity in the last 12 months: 0 insider purchases, 1 insider sale (1 under pre-arranged plans), 0 Congress purchases, 0 Congress sales, 1 fund report of opening or adding and 1 fund report of trimming or selling out (13F, quarter-end snapshots).
33 certified in FY2026 Q3, vs 40 a year earlier. 33 positions in total, median offered wage $159K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Vanguard Capital Management
Schedule 13G: passive · filed Apr 29, 2026 · 4.98M shares
FMR LLC
Schedule 13G: passive · filed Aug 6, 2026 · 4.06M shares
BlackRock, Inc.
Schedule 13G: passive · filed Jan 21, 2026 · 4.11M shares
Capital International Investors
Schedule 13G: passive · filed May 14, 2026 · 3.91M shares
Capital World Investors
Schedule 13G: passive · filed Aug 12, 2026 · 3.57M shares
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
Short sale volume: 62.6% of the volume reported to FINRA over the last 20 trading days was marked short, above its 1-year average of 57.2%. FINRA daily files, to Oct 5, 2026.
Fails to deliver: 16K shares (about $2.56M) were not delivered on time for settlement on Sep 3, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.
Certain Clear Aligners and Components Thereof; Notice of a Commission Determination Not To Review an Initial Determination Granting In Part a Motion To Amend the Complaint and Notice of Investigation
Notice · International Trade Commission
Certain Clear Aligners and Components Thereof; Institution of Investigation
Notice · International Trade Commission
Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
Notice · International Trade Commission
Federal rules, proposed rules and notices that name the company by its legal name, from the Federal Register. Being named is not the same as being the target of a rule.